Results 41 to 50 of about 2,703,409 (308)

Preoperative Hormone Therapy in the Treatment of Breast Cancer: What Do We Know So Far?

open access: yesКреативная хирургия и онкология, 2022
Breast cancer is the most common malignant disease in the world. One of the methods of treating breast cancer is neoadjuvant chemotherapy. Neoadjuvant chemotherapy (NCT) is now the standard of care for locally advanced breast cancer.
V. V. Vorotnikov   +6 more
doaj   +1 more source

Real-world analysis of leuprorelin acetate microspheres-based neoadjuvant therapy for patients with high-risk prostate cancer

open access: yesFrontiers in Oncology
ObjectiveBoennuokang® leuprorelin acetate microspheres show a certain efficacy in patients with prostate cancer, but its utilization as neoadjuvant therapy in patients with high-risk prostate cancer remains unclear.
Changde Fu   +5 more
doaj   +1 more source

Neoadjuvant therapy for breast cancer [PDF]

open access: yesTumori Journal, 2019
Objective: To evaluate the frequency of neoadjuvant therapy (NT) in women with stage I–III breast cancer in Italy and whether it is influenced by biological characteristics, screening history, and geographic area.
Lucia Mangone   +10 more
openaire   +3 more sources

Visual analysis of the research hotspots in neoadjuvant therapy for patients with gastric cancer

open access: yesFrontiers in Gastroenterology, 2023
ObjectiveThis study aimed to analyze the research hotspots and frontiers in the field of neoadjuvant therapy for patients with gastric cancer (GC) using bibliometric and identify its developmental trends.MethodsThe literature related to neoadjuvant ...
Tianxing Chen   +6 more
doaj   +1 more source

Neoadjuvant Therapy for Rectal Cancer [PDF]

open access: yesDiseases of the Colon & Rectum, 2018
A 63-year-old man presents to his primary care doctor with a one-month history of blood in his stools. He is referred for a colonoscopy and found to have a friable mass along the anterior wall just proximal to the second rectal fold. A biopsy confirms moderately-differentiated adenocarcinoma.
Ira L, Leeds, Sandy H, Fang
openaire   +2 more sources

Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma

open access: yesFrontiers in Immunology, 2023
PurposeIn patients with resectable esophageal squamous cell carcinoma (ESCC), neoadjuvant therapy increased the curative resection rate, disease-free survival, and overall survival for patients with resectable ESCC.
Xin Nie   +21 more
doaj   +1 more source

Recent Progress in the Neoadjuvant Treatment Strategy for Locally Advanced Esophageal Cancer

open access: yes, 2021
Neoadjuvant therapies, primarily chemotherapy and chemoradiotherapy, are able to improve the overall survival (OS) in patients with locally advanced resectable esophageal cancer (EC) based on the results of several randomized clinical trials.
Sicong Hou   +4 more
core   +1 more source

Cancer nanomedicine in preoperative therapeutics: Nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy

open access: yesBioactive Materials, 2023
Surgical resection remains a mainstay in the treatment of malignant solid tumors. However, the use of neoadjuvant treatments, including chemotherapy, radiotherapy, phototherapy, and immunotherapy, either alone or in combination, as a preoperative ...
Xiaogang Qu   +5 more
doaj   +1 more source

Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer

open access: yes, 2021
Complete surgical resection is the cornerstone of curative therapy for resectable pancreatic adenocarcinoma. Upfront surgery is the gold standard, but it is rarely curative.
Thierry Conroy   +3 more
core   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy